Rhythm Pharmaceuticals (RYTM) Prepaid Assets (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Prepaid Assets of $26.6 million for Q1 2026, up 50.76% year-over-year from $17.7 million in Q1 2025, and up 1.87% quarter-over-quarter from $26.1 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Prepaid Assets (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Prepaid Assets for 11 consecutive years, with $26.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 50.76% year-over-year to $26.6 million; the TTM figure through Mar 2026 stood at $26.6 million (up 50.76% YoY), while the FY2025 annual figure was $26.1 million, up 59.52% from the prior year.
- Prepaid Assets climbed to $26.6 million in Q1 2026 per RYTM's latest filing, from $26.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $26.6 million in Q1 2026 and bottomed at $6.7 million in Q4 2023.
- Historically, Prepaid Assets has averaged $14.1 million across 5 years, with a median of $11.4 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets fell 28.96% — and 2025, when it jumped 185.24%.
- Rhythm Pharmaceuticals' Prepaid Assets stood at $7.4 million in 2022, then slipped by 10.02% to $6.7 million in 2023, then jumped by 145.53% to $16.4 million in 2024, then surged by 59.52% to $26.1 million in 2025, then rose by 1.87% to $26.6 million in 2026.
- Business Quant data shows RYTM's Prepaid Assets at $26.6 million in Q1 2026, $26.1 million in Q4 2025, and $23.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.74 Mn |
| Mar 31, 2026 | 26.62 Mn |
| Dec 31, 2025 | 26.13 Mn |
| Sep 30, 2025 | 23.61 Mn |
| Jun 30, 2025 | 24.66 Mn |
| Mar 31, 2025 | 17.66 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 8.75 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 11.35 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 7.64 Mn |
| Jun 30, 2023 | 10.27 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 7.42 Mn |
| Sep 30, 2022 | 10.75 Mn |
| Jun 30, 2022 | 12.03 Mn |
| Mar 31, 2022 | 11.62 Mn |
| Dec 31, 2021 | 3.99 Mn |
| Sep 30, 2021 | 7.28 Mn |